Complete Clinical Assessment for Wegovy in Minutes
Online Prescription Process for Switching to Wegovy from Mounjaro
Switching to Wegovy from Mounjaro through our online prescription service removes the complexity of traditional healthcare pathways. Our 3-minute clinical assessment covers your medical history, current medications, BMI calculation, and any contraindications specific to semaglutide therapy. Licensed UK prescribers review every application individually, ensuring switching to Wegovy from Mounjaro is clinically appropriate for your circumstances. The assessment includes questions about your previous experience with GLP-1 medications, which helps prescribers determine the most suitable starting dose and escalation schedule.
Unlike traditional GP consultations that may require weeks of waiting, our online prescription process typically takes 3 working days for standard review, or 24 hours with express service. This efficiency is particularly valuable when switching to Wegovy from Mounjaro, as treatment continuity supports consistent weight management progress. Our GPhC-registered pharmacy (#9012878) ensures all prescriptions meet MHRA regulatory standards, with comprehensive safety checks built into every stage of the process.
Wegovy Pricing and Bundle Options for Treatment Transitions
When switching to Wegovy from Mounjaro, understanding the cost structure helps with treatment planning. Wegovy starter doses begin at £79.99 for 0.25mg pens (weeks 1-4), progressing to £94.99 for 0.5mg (weeks 5-8), then £99.99 for 1mg (weeks 9-12). The therapeutic doses are £139.99 for 1.7mg (weeks 13-16) and £209.99 for the 2.4mg maintenance dose. New customers can apply discount code FIRST40 at checkout, whilst returning customers use code DOSE25 to reach these final prices.
Our bundle options provide convenience for patients switching to Wegovy from Mounjaro who want Reliable Supply continuity. The Intro Trio (0.25mg, 0.5mg & 1mg) costs £299.99, covering your first 12 weeks of treatment with a single order. For those wanting a gentler transition, the Gentle Start Trio includes two 0.25mg pens plus one 0.5mg pen for £269.99, allowing extended time at the initial dose. Bundle deliveries arrive in temperature-controlled packaging, ensuring medication integrity throughout the dose escalation process.
Clinical Evidence Supporting Wegovy for Weight Management
The STEP clinical trial programme provides robust evidence for Wegovy's effectiveness in weight management. STEP 1 demonstrated an average weight loss of approximately 15% at 68 weeks in patients taking Wegovy alongside diet and exercise, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). STEP 2 showed sustained results in patients with type 2 diabetes, whilst STEP 5 confirmed long-term efficacy over 2 years.
When switching to Wegovy from Mounjaro, patients should understand that both medications have demonstrated clinical efficacy through different mechanisms. The recent SELECT cardiovascular outcomes trial showed Wegovy reduced major cardiovascular events by 20% in adults with established cardiovascular disease. These studies inform prescribing decisions when patients are switching to Wegovy from Mounjaro based on individual clinical profiles and treatment goals.
How Wegovy Works as a GLP-1 Receptor Agonist
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the action of a natural hormone involved in appetite regulation and glucose control. When patients are switching to Wegovy from Mounjaro, they transition from a dual GIP/GLP-1 agonist to a selective GLP-1 approach. Wegovy works by slowing gastric emptying, which promotes feelings of fullness after smaller meals. The medication also acts on appetite centres in the brain, potentially reducing food cravings and the preoccupation with food that many patients experience. These mechanisms support weight management when used alongside a reduced-calorie diet and increased physical activity, as required by the MHRA-licensed indication.
Ordering Process from Assessment to Delivery
The ordering process for switching to Wegovy from Mounjaro begins with our comprehensive online clinical assessment, which takes approximately 3 minutes to complete. You'll provide information about your weight management history, current medications, medical conditions, and treatment goals. Licensed UK prescribers review each application within 3 working days (or 24 hours with express service), checking for drug interactions and contraindications. Once approved, your prescription is dispensed from our GPhC-registered pharmacy (#9012878) and dispatched via next-day delivery in temperature-controlled packaging. The entire process from assessment to receipt typically takes 4-5 working days, ensuring minimal disruption when switching to Wegovy from Mounjaro.
Storage Requirements and Practical Considerations
Wegovy requires refrigerated storage at 2-8°C before first use, but offers flexibility with up to 6 weeks at room temperature below 30°C once removed from the fridge. This storage advantage is relevant when switching to Wegovy from Mounjaro, as Mounjaro only maintains stability for 21 days at room temperature. Wegovy uses Novo Nordisk's FlexTouch pen system, which delivers pre-measured doses subcutaneously once weekly. The mandatory dose escalation schedule cannot be shortened, starting at 0.25mg and increasing every 4 weeks until reaching the 2.4mg maintenance dose. Patients switching to Wegovy from Mounjaro should discuss their previous dose tolerance with prescribers, though the escalation schedule remains standardised for safety reasons.
Treatment Transition Considerations for Medication Switches
When switching to Wegovy from Mounjaro, timing considerations help maintain treatment continuity without overlapping medications. Most prescribers recommend a washout period between stopping tirzepatide and starting semaglutide, though the exact duration depends on individual factors. Our clinical assessment specifically addresses previous GLP-1 medication experience, including tolerance, efficacy, and any adverse effects encountered with prior treatment.
The transition from switching to Wegovy from Mounjaro may involve starting at the standard 0.25mg dose regardless of your previous Mounjaro dose, as different medications require independent dose escalation for safety monitoring. Our prescribers provide guidance on managing any temporary changes in appetite or side effect profiles during the switch. This personalised approach ensures switching to Wegovy from Mounjaro aligns with your clinical needs and treatment objectives.
Complete Your Wegovy Prescription Today
Ready to begin switching to Wegovy from Mounjaro through our streamlined online service? Complete your clinical assessment now and receive prescriber review within 3 working days, with next-day delivery once approved. New customers can use discount code FIRST40 at checkout, whilst returning patients apply code DOSE25 for final pricing. Visit our Wegovy collection at https://everydaymeds.co.uk/collections/wegovy to start your prescription-only medicine journey with confidence. Our comprehensive service includes ongoing clinical support, delivery tracking, and access to our patient care team throughout your weight management journey. Take the first step towards switching to Wegovy from Mounjaro with the UK's trusted online prescription service.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
